On the Radar Issue 636 is now available.
2024
Presentation
These slides can be used and/or adapted to present to clinicians on the Heavy Menstrual Bleeding Clinical Care Standard. Content covers why the standard was developed, an overview of the quality statements, and three case studies.
2024
Guide, user guide or guidelines
This resource is designed to assist HealthPathways clinical editors to align local pathways with the standard. It summarises key aspects of the standard relevant to a general practitioner (GP) consultation.
2024
Audit, monitoring or reporting tool
This tool is provided to support acute public hospitals to calculate the age-standardised rate for Indicator 9a-Hospital rate of hysterectomy per 100 episodes.
2024
Fact sheet or brochure
This fact sheet provides an overview of treatment options for heavy menstrual bleeding. Its primary purpose is to support discussions between clinicians and women about their options.
Heavy Menstrual Bleeding - Hayley's story
In this video, Hayley explains the disruptive impact that heavy menstrual bleeding has had on her life, and her experience with different treatments. She shares her advice for other women who experience heavy menstrual bleeding.
The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard includes links to resources that may help healthcare services and clinicians to implement the standard. These resources are listed under the relevant quality statements below.
Clinicians, consumers and healthcare services have been consulted during the development of the Standard.
Endorsing organisations
The Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard has been endorsed by the following organisations:
Quality statements
The quality statements describe the expected standard for key components of patient care. By describing what each statement means, they support: